|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online August 21, 2002 as doi:10.1096/fj.02-0420fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Internal Medicine/Pulmonary and Critical Care Medicine, Justus-Liebig-University, D-35385 Giessen, Germany; and
* Institute of Veterinary Physiology, University of Zürich, CH-8057 Zürich, Switzerland
2Correspondence: Department of Internal Medicine 2, Klinikstr. 36, D-35392 Giessen, Germany. E-mail: Joerg.Haenze{at}innere.med.uni-giessen.de
SPECIFIC AIMS
Sustained generalized alveolar hypoxia as it occurs in chronic obstructive and restrictive lung disease, as well as in association with alveolar hypoventilation due to neuromuscular disorders, leads to pulmonary hypertension and cor pulmonale. This phenomenon is the predominant disease of the lung vasculature and the leading cause of early invalidity and death due to right heart failure. It is characterized by vascular smooth muscle cell (SMC) hyperplasia; media thickening and de novo muscularization of small precapillary vessels are the key features of a vascular remodeling process with progressive narrowing of the vascular lumen.
The intra- and intercellular molecular mechanisms of hypoxia sensing and signaling that underlie this remodeling response in hypoxic pulmonary vessels, are still under investigation. We tested the hypothesis that besides vascular SMC, adventitial fibroblasts (FB) may substantially contribute to the hypoxia-driven proliferative vascular response and analyzed the putative role of hypoxia-inducible factors (HIF). Three subtypes of HIF are currently known (HIF-1
, HIF-2
, HIF-3
); they all affect gene regulation via a conserved hypoxia-responsive element (HRE).
PRINCIPAL FINDINGS
In a hypoxic atmosphere, strong proliferation of pulmonary artery fibroblasts (FBPA) was noted whereas isolated SMCPA did not display a proliferative response to hypoxia. However, the coculture of SMCPA with FBPA under conditions of hypoxia markedly amplified SMCPA growth (Fig. 1
). This effect was fully reproduced by the use of conditioned serum-free cell supernatant from FBPA incubated under conditions of hypoxia, which was then transferred to normoxic SMCPA.
|
Complete reproduction of the proliferative SMCPA response by serum-free supernatant originating from hypoxic fibroblasts and transferred to normoxic SMC strongly suggests hypoxia sensing by the fibroblasts and intercellular signaling to the adjacent SMC as an underlying mechanism. On the molecular level, the currently known hypoxia-inducible transcription factors HIF-1
, HIF-2
, and HIF-3
subtypes were all found to be up-regulated in the hypoxic fibroblasts, HIF-1
being documented at the protein level and HIF-2
and HIF-3
being analyzed at the mRNA level (Fig. 2
a, b). Moreover, an HRE-dependent reporter gene assay showed strong activation in pulmonary artery fibroblasts in response to hypoxia (Fig. 2c
). Use of the transcription decoy technique, currently applied to HIF as a novel approach, was found to fully block the capacity of hypoxic fibroblasts to elicit SMCPA growth, thus providing further strong evidence that the hypoxia-induced gene expression in the fibroblasts and the proliferative SMC response were causally linked. Since the HIF decoy fragment carries the same HRE sequence as in the HRE-TK and HRE-SV40 reporter vector experiments, we suggest a specific HIF decoy effect on the suppression of hypoxia-dependent target genes controlled by consensus HRE sequences.
|
CONCLUSIONS
The experimental data suggest that 1) pulmonary vascular adventitial fibroblasts respond to hypoxia by secreting soluble factors that induce proliferation of adjacent smooth muscle cells; 2) these soluble factors are shown to be controlled or encoded by the expression of genes carrying a hypoxia-responsive element (DNA binding domain for HIF transcription factors) in their regulatory regions; 3) HIF transcription factor decoy, a strategy for inhibition of HIF-dependent gene regulation used for the first time in this study, suppresses fibroblast-dependent, hypoxia-induced SMCPA proliferation and thus may be considered as a new therapeutic tool for treatment of pulmonary hypertension (Fig. 3
).
|
The findings are related to the state of the field with respect to the recent exploration of hypoxic-dependent gene regulation by three hypoxia-inducible transcription factors (HIF-1
, HIF-2
, HIF3
). These factors have been identified on the molecular level and shown to be functionally involved in the induction of angiogenesis, anaerobic glycolysis, and polycythemia. Here we describe a new organ specific role of these factors in the lung vasculature and offer a new molecular to interfere with HIF-dependent gene regulation. We also show a specific role of adventitial fibroblasts in pulmonary vascular remodeling that confirms suggestions from previous studies that these cells are involved in the pathogenetic sequelae of pulmonary hypertension.
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.02-0420fje; to cite this article, use FASEB J. 10.1096/fj.02-0420fje. ![]()
This article has been cited by other articles:
![]() |
N. Li, L. Chen, F. Yi, M. Xia, and P.-L. Li Salt-Sensitive Hypertension Induced by Decoy of Transcription Factor Hypoxia-Inducible Factor-1{alpha} in the Renal Medulla Circ. Res., May 9, 2008; 102(9): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dony, Y-J. Lai, R. Dumitrascu, S. S. Pullamsetti, R. Savai, H. A. Ghofrani, N. Weissmann, C. Schudt, D. Flockerzi, W. Seeger, et al. Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition Eur. Respir. J., March 1, 2008; 31(3): 599 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamashita, O. Ohneda, M. Nagano, M. Iemitsu, Y. Makino, H. Tanaka, T. Miyauchi, K. Goto, K. Ohneda, Y. Fujii-Kuriyama, et al. Abnormal Heart Development and Lung Remodeling in Mice Lacking the Hypoxia-Inducible Factor-Related Basic Helix-Loop-Helix PAS Protein NEPAS Mol. Cell. Biol., February 15, 2008; 28(4): 1285 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Ray, S. Arab, Y. Deng, P. Liu, L. Penn, D. W. Courtman, and M. E. Ward Oxygen regulation of arterial smooth muscle cell proliferation and survival Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H839 - H852. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mittal, M. Roth, P. Konig, S. Hofmann, E. Dony, P. Goyal, A.-C. Selbitz, R. T. Schermuly, H. A. Ghofrani, G. Kwapiszewska, et al. Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature Circ. Res., August 3, 2007; 101(3): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pak, A. Aldashev, D. Welsh, and A. Peacock The effects of hypoxia on the cells of the pulmonary vasculature Eur. Respir. J., August 1, 2007; 30(2): 364 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karakiulakis, E. Papakonstantinou, A. J. Aletras, M. Tamm, and M. Roth Cell Type-specific Effect of Hypoxia and Platelet-derived Growth Factor-BB on Extracellular Matrix Turnover and Its Consequences for Lung Remodeling J. Biol. Chem., January 12, 2007; 282(2): 908 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, K. A. Fagan, and M. G. Frid Hypoxia-Induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms Circ. Res., September 29, 2006; 99(7): 675 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wade, S. H. Guttentag, L. W. Gonzales, K. L. Maschhoff, J. Gonzales, V. Kolla, S. Singhal, and P. L. Ballard Gene Induction during Differentiation of Human Pulmonary Type II Cells In Vitro Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das Role of the Adventitia in Pulmonary Vascular Remodeling Physiology, April 1, 2006; 21(2): 134 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Haider, R. A. Bucek, A. G. Giurgea, G. Maurer, H. Glogar, E. Minar, M. Wolzt, M. R. Mehrabi, and M. Baghestanian PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2066 - H2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Stenmark, N. J. Davie, J. T. Reeves, and M. G. Frid Hypoxia, leukocytes, and the pulmonary circulation J Appl Physiol, February 1, 2005; 98(2): 715 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Nakayama, H Enzan, E Miyazaki, N Kuroda, M Toi, M Hiroi, and W Yasui Presence of vascular adventitial fibroblastic cells in diffuse-type gastric carcinomas J. Clin. Pathol., September 1, 2004; 57(9): 970 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zagorski, J. Debelak, M. Gellar, J. A. Watts, and J. A. Kline Chemokines Accumulate in the Lungs of Rats with Severe Pulmonary Embolism Induced by Polystyrene Microspheres J. Immunol., November 15, 2003; 171(10): 5529 - 5536. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |